Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin Inizan
Institution:
OTR3 (France)
Observed institution:
OTR3 (France)
ORCID:
0009-0005-9813-9039
Observed ORCID:
0009-0005-9813-9039
OpenAlex ID:
A5111314880
Intra-arterial Injection of OTR4132, a Novel Neuroprotector in Acute Ischemic Stroke: The MaTRISS Trial
2025
·
Xavier Barreau
, René Anxionnat
, et al.
·
Clinical Drug Investigation
·
2
PDF
A Prospective Cohort Study of Hard‐to‐Heal Chronic Foot and Leg Wounds Followed for up to 20 Weeks After Initiation of ReGenerating Tissue Agents (RGTA) Technology as an Add‐on to Optimal Local Care
2026
·
Serge Ynesta
, Marion Mourgues
, et al.
·
International Wound Journal
PDF
O02 First in man study of OTR4132, a heparan sulfate mimetic neuroprotector, injected intra-arterially after endovascular thrombectomy in patients with acute ischemic stroke: the matriss trial
2024
·
Xavier Barreau
, René Anxionnat
, et al.
·
Journal of NeuroInterventional Surgery
PDF
Show more works
View as search
Works count:
3
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type